{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-257692","form_type":"8-K","ticker":"DNA","cik":"0001830214","company_name":"Ginkgo Bioworks Holdings, Inc.","filed_at":"2022-10-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.489129+00:00","generated_at":"2026-06-23T05:40:35.916622+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Ginkgo recasts 2021 financials into Foundry and Biosecurity segments","bullets":["Historical segment data revised to two segments: Foundry and Biosecurity (previously one segment).","No changes to previously reported total revenue, net income, or cash flows.","Segment change was implemented in Q1 2022; this filing provides recast comparative periods.","Recast information intended for incorporation by reference into future registration statements."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-257692","json":"https://secwatch.observer/filing/0001193125-22-257692.json","markdown":"https://secwatch.observer/filing/0001193125-22-257692.md","text":"https://secwatch.observer/filing/0001193125-22-257692.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1830214/000119312522257692/0001193125-22-257692-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1830214/000119312522257692/d238484d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T05:40:35.916622+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}